Plain-English translation of NCT06295965 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The CHANCES study is looking at how cancer treatments — particularly chemotherapy and PARP inhibitors — can sometimes cause changes in blood cell production over time. Researchers want to understand when and why these changes happen, and whether they lead to new blood disorders. By collecting blood samples and reviewing medical records from patients like you, they hope to identify early warning signs and eventually improve treatment safety.
Some cancer patients develop blood problems after receiving chemotherapy or targeted drugs, but doctors don't fully understand why this happens or how to predict it. This study aims to fill that gap by tracking blood cell changes in a large group of patients, which could help doctors better protect patients undergoing similar treatments in the future.
You likely qualify if…
You likely don't qualify if…
You will donate blood samples and complete brief surveys about your health history and any symptoms you've noticed. Researchers will also review your medical records to track what treatments you've received and any blood-related changes over time. There is no set duration — you can participate as long as you're willing, and the study team will contact you periodically to check in and collect additional samples if needed.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States